Literature DB >> 8031128

Thiol-mediated NTA-Fe(III) reduction and lipid peroxidation.

N Spear1, S D Aust.   

Abstract

The nephrotoxicity of nitrilotriacetate chelated Fe(III) (NTA-Fe(III)) has been linked to the metabolism of glutathione (GSH) by gamma-glutamyl transpeptidase and a dipeptidase. The products of these enzymes are cysteinyl-glycine (cys-gly) and cysteine (cys), which are proposed to be the reductants of NTA-Fe(III) to cause oxidative damage to various biomolecules. The ability of cys-gly and cys to cause in vitro NTA-Fe(III)-dependent lipid peroxidation correlated directly with their ability to reduce NTA-Fe(III). GSH reduced iron at a much slower rate and did not stimulate lipid peroxidation. It has been proposed that GSH, cys-gly and cys reduce iron at different rates because their thiols have different pKas. However, increasing the amount of GS-, by raising the pH, did not cause a corresponding increase in the rate of iron reduction. The monomethyl ester of GSH reduced NTA-Fe(III) at the same rate as GSH, but the dimethyl ester of GSH reduced NTA-Fe(III) approximately 30 times faster. From this we conclude that GSH does not reduce NTA-Fe(III) at the same rate as cys-gly and cys because of the liganding between GSH and the iron.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031128     DOI: 10.1006/abbi.1994.1299

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Targeted metabolomics and mathematical modeling demonstrate that vitamin B-6 restriction alters one-carbon metabolism in cultured HepG2 cells.

Authors:  Vanessa R da Silva; Maria A Ralat; Eoin P Quinlivan; Barbara N DeRatt; Timothy J Garrett; Yueh-Yun Chi; H Frederik Nijhout; Michael C Reed; Jesse F Gregory
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-13       Impact factor: 4.310

2.  Prospective study of serum cysteine and cysteinylglycine and cancer of the head and neck, esophagus, and stomach in a cohort of male smokers.

Authors:  Eugenia H Miranti; Neal D Freedman; Stephanie J Weinstein; Christian C Abnet; Jacob Selhub; Gwen Murphy; Lena Diaw; Satu Männistö; Philip R Taylor; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Am J Clin Nutr       Date:  2016-08-17       Impact factor: 7.045

3.  Possible role of membrane gamma-glutamyltransferase activity in the facilitation of transferrin-dependent and -independent iron uptake by cancer cells.

Authors:  Silvia Dominici; Lisa Pieri; Mario Comporti; Alfonso Pompella
Journal:  Cancer Cell Int       Date:  2003-05-14       Impact factor: 5.722

4.  A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome.

Authors:  Stephanie Seneff; Robert M Davidson; Ann Lauritzen; Anthony Samsel; Glyn Wainwright
Journal:  Theor Biol Med Model       Date:  2015-05-27       Impact factor: 2.432

5.  γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.

Authors:  Timothy T Bui; Ryan T Nitta; Suzana A Kahn; Seyed-Mostafa Razavi; Maya Agarwal; Parvir Aujla; Sharareh Gholamin; Lawrence Recht; Gordon Li
Journal:  BMC Cancer       Date:  2015-04-07       Impact factor: 4.430

6.  Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate.

Authors:  T Umemura; R Hasegawa; K Sai-Kato; A Nishikawa; F Furukawa; S Toyokuni; K Uchida; T Inoue; Y Kurokawa
Journal:  Jpn J Cancer Res       Date:  1996-09

Review 7.  The Role of Ferric Nitrilotriacetate in Renal Carcinogenesis and Cell Death: From Animal Models to Clinical Implications.

Authors:  Yasumasa Okazaki
Journal:  Cancers (Basel)       Date:  2022-03-15       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.